News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- CDC encourages more Americans to consider N95 masks
- Shrekli hit with $64.6M verdict, lifetime pharma ban in antitrust case
- Pfizer's Cibinqo snags FDA approval to challenge Sanofi and Regeneron's Dupixent in eczema
- STAT+: Martin Shkreli is ordered to pay $64 million and is banned from the pharma industry for life
- Medtronic projects pain relief, longer battery life with low-power spinal cord stimulation
- Opinion: Eliminating the FDA’s blood donation ban on men who have sex with men would help ease the U.S. shortage
- Novo Nordisk comes out clean in $1.8B investor lawsuit alleging insulin misdirection
- Medicare faces blowback over plan to limit coverage of Biogen's Alzheimer's drug
- Emergent BioSolutions founder El-Hibri bids adieu after CDMO's turbulent 2021
- Califf advances in FDA chief nomination process but committee vote indicates he's no slam-dunk choice
- 'Shots on goal' to 'deterministic' drug development: Flagship CEO, Moderna Chair Noubar Afeyan pens first annual letter
- STAT+: Up and down the ladder: The latest comings and goings
- JPM 2022: With Voxzogo approvals adding up, BioMarin is underway with its 'biggest launch,' CEO says
- Idorsia makes friends with Jen Aniston for new sleep campaign, as it preps for insomnia drug launch
- Verana Health lands J&J, Novo backing in $150M round to fund real-world database for drug, device development